The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The combination of venetoclax, lenalidomide, and rituximab in patients with newly diagnosed mantle cell lymphoma induces high response rates and MRD undetectability.
 
Tycel Jovelle Phillips
Honoraria - Bayer; Genentech; Gilead Sciences; Incyte; Pharmacyclics; Seagen
Consulting or Advisory Role - Bayer; Celgene; Curis; Genentech; Gilead Sciences; Gilead Sciences; Incyte; Kite/Gilead; Pharmacyclics; Seagen
Speakers' Bureau - Genmab
Research Funding - Abbvie; Bayer; Pharmacyclics/Janssen
 
Alexey Valeryevich Danilov
Stock and Other Ownership Interests - Abbvie
Honoraria - Dava Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Curis; Genentech/Roche; Gilead Sciences; Juno Therapeutics; Karyopharm Therapeutics; Seagen; Teva; TG Therapeutics; Verastem
Research Funding - Aptose Biosciences; AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences; Takeda; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche
 
David Alan Bond
Honoraria - Seagen
Travel, Accommodations, Expenses - Novartis
 
Alex Francisco Herrera
Consulting or Advisory Role - Bristol-Myers Squibb; Kite, a Gilead company; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Kite, a Gilead company (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Kami J. Maddocks
Honoraria - ADC Therapeutics; BMS; Celgene; Genmab; Karyopharm Therapeutics; Kite, a Gilead company; MorphoSys; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Merck; Pharmacyclics
 
Sumana Devata
No Relationships to Disclose
 
Yasmin Karimi
No Relationships to Disclose
 
Shannon Carty
No Relationships to Disclose
 
Ryan A. Wilcox
No Relationships to Disclose
 
Mark Stefan Kaminski
No Relationships to Disclose
 
Sami N. Malek
Stock and Other Ownership Interests - Abbvie
 
Moshe Talpaz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; Novartis
Research Funding - Bristol-Myers Squibb/Celgene; Incyte; Novartis
 
Leslie Popplewell
No Relationships to Disclose